James W. Tetrud
Stanford Medicine(US)Parkinson's Institute and Clinical Center(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Genetic Neurodegenerative Diseases, Botulinum Toxin and Related Neurological Disorders, Neurological diseases and metabolism
Most-Cited Works
- → Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis(1983)4,875 cited
- → Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure(1999)968 cited
- → The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease(1989)645 cited
- → Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)(1985)624 cited
- → Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by 1-Methyl-4-Phenyl-L,2,3,6-Tetrahydropyridine (MPTP)(1992)495 cited
- → A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease(2014)383 cited